We are live on ! Find out more
Bank of New York Mellon

Bank of New York Mellon Portfolio holdings

AUM $609B
1-Year Est. Return 40.19%
 

Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.

This Fund
S&P 500
This Quarter Est. Return
-14.25%
1 Year Est. Return
+40.19%
3 Year Est. Return
+118.86%
5 Year Est. Return
+156%
10 Year Est. Return
+606.23%
AUM
$438B
AUM Growth
-$78.4B
Cap. Flow
+$5.92B
Cap. Flow %
1.35%
Top 10 Hldgs %
19.19%
Holding
4,820
New
167
Increased
1,786
Reduced
2,376
Closed
241

Top Buys

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$305M
2
TSLA icon
Tesla
TSLA
+$304M
3
XOM icon
ExxonMobil
XOM
+$277M
4
WBD icon
Warner Bros
WBD
+$263M
5
LIN icon
Linde
LIN
+$237M

Sector Composition

Rank Sector Weight
1 Technology 23.18%
2 Healthcare 14.61%
3 Financials 11.99%
4 Consumer Discretionary 9.25%
5 Industrials 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FGH
4251
DELISTED
FG Group Holdings Inc.
FGH
$34K ﹤0.01%
14,062
TRHC
4252
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$34K ﹤0.01%
12,981
-70,035
-84% -$263K
ADN
4253
DELISTED
Advent Technologies
ADN
$33K ﹤0.01%
443
-1,656
-79% -$100K
ASMB icon
4254
Assembly Biosciences
ASMB
$594M
$33K ﹤0.01%
1,322
AXDX
4255
DELISTED
Accelerate Diagnostics
AXDX
$33K ﹤0.01%
3,279
-7,618
-70% -$67.3K
PAVM icon
4256
PAVmed
PAVM
$33.9M
$33K ﹤0.01%
78
-391
-83% -$189K
TRVN
4257
DELISTED
Trevena, Inc.
TRVN
$33K ﹤0.01%
129
-662
-84% -$146K
BCLI
4258
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$32K ﹤0.01%
769
-48
-6% -$2.16K
CGC
4259
Canopy Growth
CGC
$426M
$32K ﹤0.01%
1,106
-23,028
-95% -$1.2M
CRDF icon
4260
Cardiff Oncology
CRDF
$76.6M
$32K ﹤0.01%
14,485
-100,906
-87% -$169K
DNN icon
4261
Denison Mines
DNN
$2.95B
$32K ﹤0.01%
32,881
+2,621
+9% +$3.36K
REFR icon
4262
Research Frontiers
REFR
$15.2M
$32K ﹤0.01%
18,393
IVF
4263
INVO Fertility Inc
IVF
$1.73M
$32K ﹤0.01%
+2
New +$79.3K
AEMD icon
4264
Aethlon Medical
AEMD
$1.54M
$31K ﹤0.01%
7
AUID icon
4265
authID Inc
AUID
$7.91M
$31K ﹤0.01%
+1,997
New +$49.1K
DARE icon
4266
Dare Bioscience
DARE
$20.5M
$31K ﹤0.01%
2,109
+231
+12% +$3.48K
FSM icon
4267
Fortuna Silver Mines
FSM
$3.1B
$30K ﹤0.01%
10,575
-200
-2% -$696
GALT icon
4268
Galectin Therapeutics
GALT
$356M
$30K ﹤0.01%
23,079
IKT icon
4269
Inhibikase Therapeutics
IKT
$378M
$29K ﹤0.01%
6,552
-45
-0.7% -$265
LITS
4270
Lite Strategy Inc
LITS
$30.5M
$29K ﹤0.01%
2,415
-16,073
-87% -$175K
XELA
4271
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$29K ﹤0.01%
63
-1
-2% -$1.09K
CLIR icon
4272
ClearSign Technologies
CLIR
$28.9M
$28K ﹤0.01%
2,326
-128
-5% -$1.65K
CNF
4273
CNFinance Holdings
CNF
$41M
$28K ﹤0.01%
+1,104
New +$31.3K
DFTX
4274
Definium Therapeutics
DFTX
$5.9B
$28K ﹤0.01%
2,853
-59,573
-95% -$754K
PTN
4275
Palatin Technologies
PTN
$17.8M
$28K ﹤0.01%
81

Similar funds

Bank of New York Mellon's Q2 2022 Portfolio in Review

As of Q2 2022, Bank of New York Mellon held 4,820 positions worth $438B, down 15% from $516B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Bank of New York Mellon's Q2 2022 filing shows 167 new, 1,786 increased, 2,376 reduced and 241 closed positions. Its largest new stake was Hess Midstream: 1,736,004 shares worth $48.6M. The largest sale was Apple, an estimated $403M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Bank of New York Mellon's largest Q2 2022 buy was Hess Midstream: 1,736,004 shares worth $48.6M.
  • Bank of New York Mellon added most to Goldman Sachs in Q2 2022, an estimated $305M increase.
  • Bank of New York Mellon's biggest Q2 2022 reduction was Apple, cutting an estimated $403M.
  • Bank of New York Mellon fully exited Cerner Corp in Q2 2022, selling an estimated $371M.
  • Bank of New York Mellon's ten largest holdings make up 19% of its $438B portfolio in Q2 2022.
  • Bank of New York Mellon opened 167 new positions and closed 241 in Q2 2022.
  • Bank of New York Mellon's portfolio value fell 15% quarter-over-quarter to $438B.

Based on Bank of New York Mellon's 13F filing for Q2 2022, filed 15 Aug 2022.